Lymecycline reverses acquired EGFR-TKI resistance in non–small-cell lung cancer by targeting GRB2
Titel:
Lymecycline reverses acquired EGFR-TKI resistance in non–small-cell lung cancer by targeting GRB2
Auteur:
Chen, Yang Wu, Jie Yan, Hongfei Cheng, Yang Wang, Yizhe Yang, Yi Deng, Mingming Che, Xiaofang Hou, Kezuo Qu, Xiujuan Zou, Dan Liu, Yunpeng Zhang, Ye Hu, Xuejun